trending Market Intelligence /marketintelligence/en/news-insights/trending/kddtjnq_b-2kpobvg3mrlg2 content esgSubNav
In This List

Thermo Fisher says Patheon unit's former CEO to join board

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Thermo Fisher says Patheon unit's former CEO to join board

Thermo Fisher Scientific Inc. said its board elected James Mullen to serve as a director, effective Nov. 8.

Mullen was CEO of Patheon NV until it was acquired by Thermo Fisher. He also previously served as CEO and president of Biogen Inc.

Waltham, Mass.-based Thermo Fisher is a provider of analytical instruments and equipment. The company completed the acquisition of Patheon in August 2017.